Gao, Lu
Yang, Li
Zhou, Shiyuan
Zhu, Wenjuan
Han, Yue
Chen, Suning
Xue, Shengli
Wang, Ying
Qiu, Huiying
Wu, Depei
Wu, Xiaojin http://orcid.org/0000-0003-3894-0631
Funding for this research was provided by:
National Key R&D Program of China (2019YFC0840604, 2017YFA0104502)
the National Natural Science Foundation of China (Nos. 81974001, 82170222)
Natural Science Foundation of Jiangsu Province (BK20211070)
The Key Disease Program of Suzhou (LCZX202101)
National Science and Technology Major Project (2017ZX09304021)
Priority Academic Program Development of Jiangsu Higher Education Institutions
Targeted therapy and Modified Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia (H230094)
Jiangsu Province Elderly Health Research Project (LKM2023015)
Article History
Received: 2 October 2023
Accepted: 18 January 2024
First Online: 29 January 2024
Declarations
:
: The study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Soochow University in China (approval number 201487004), from the approved project “Research on the prognostic significance of newfound molecular genetic markers in patients with acute leukemia” on January 20th, 2014. Informed consent was obtained from patients in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.